Clinical Trial Search

Recruiting

Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults

NCT02272049

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Recruiting

Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration

NCT02316379

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Recruiting

Effects of Pulmonary Rehabilitation in Salt Chambers on Functional Efficiency, Respiratory Parameters, and Blood Rheology in Elderly With Respiratory Diseases.

NCT06951633

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases, +1 more
Locations: Health Resort 'Wieliczka' Salt Mine in Wieliczka Wieliczka, Poland

View Trial Details

Completed

Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine

NCT03894969

Conditions: Chronic Disease, DNA Virus Infections, Disease Attributes, +13 more
Locations: GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

GSK Investigational Site Tartu, Estonia

GSK Investigational Site Helsinki, Finland

View all 14 locations

View Trial Details

Completed

A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine

NCT03443427

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations: GSK Investigational Site Truro, Nova Scotia, Canada

GSK Investigational Site Sherbrooke, Quebec, Canada

GSK Investigational Site Würzburg, Bavaria, Germany

GSK Investigational Site Goch, North Rhine-Westphalia, Germany

View Trial Details

Completed

Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific

NCT03151395

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations: GSK Investigational Site Kowloon, Hong Kong

GSK Investigational Site Lai Chi Kok, Hong Kong

GSK Investigational Site Shatin, Hong Kong

GSK Investigational Site Iloilo City, Philippines

View all 19 locations

View Trial Details

Completed

A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults

NCT03201211

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations: GSK Investigational Site Ghent, Belgium

GSK Investigational Site Leuven, Belgium

GSK Investigational Site Wilrijk, Belgium

View Trial Details

Completed

A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.

NCT03281876

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations: GSK Investigational Site Mesa, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Palm Springs, California, United States

View all 67 locations

View Trial Details

Completed

Ventilator Hyperinflation and Hemodynamics

NCT03557645

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Failure, +2 more
Locations: Hospital Santa Martha Niterói, Rio de Janeiro, Brazil

View Trial Details

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057

NCT01587807

Conditions: Infections, Lung Diseases, Lung Injury, +5 more
Locations: GSK Investigational Site Belfast, United Kingdom

GSK Investigational Site Harrow, United Kingdom

View Trial Details

Completed

Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly

NCT01360398

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations: GSK Investigational Site Southampton, Hampshire, United Kingdom

View Trial Details

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.

NCT02547974

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations: GSK Investigational Site Ghent, Belgium

GSK Investigational Site Leuven, Belgium

GSK Investigational Site Wilrijk, Belgium

View Trial Details

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.

NCT02075541

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations: GSK Investigational Site Eskilstuna, Sweden

GSK Investigational Site Gothenburg, Sweden

GSK Investigational Site Örebro, Sweden

GSK Investigational Site Llanelli, Carmarthenshire, United Kingdom

View all 14 locations

View Trial Details

Completed

Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.

NCT01476046

Conditions: Acute Lung Injury, Lung Diseases, Lung Injury, +4 more
Locations: GSK Investigational Site Harrow, Middlesex, United Kingdom

View Trial Details

Completed

A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD

NCT01516437

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations: GSK Investigational Site Brussels, Belgium

GSK Investigational Site Ghent, Belgium

GSK Investigational Site Liège, Belgium

View Trial Details

Completed

Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

NCT01395849

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations: Not specified

View Trial Details

Completed

A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers

NCT01818024

Conditions: Lung Diseases, Lung Injury, Respiration Disorders, +4 more
Locations: GSK Investigational Site Harrow, Middlesex, United Kingdom

View Trial Details

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers

NCT01678677

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations: GSK Investigational Site Antwerp, Belgium

GSK Investigational Site Ghent, Belgium

GSK Investigational Site Wilrijk, Belgium

View Trial Details

Completed

Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects

NCT02322671

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations: GSK Investigational Site Hyderabad, India

View Trial Details

Completed

Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine

NCT01657526

Conditions: Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations: GSK Investigational Site Adelaide, South Australia, Australia

View Trial Details

Find Clinical Trials

Active filters

Clinical trials found

Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults

Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration

Effects of Pulmonary Rehabilitation in Salt Chambers on Functional Efficiency, Respiratory Parameters, and Blood Rheology in Elderly With Respiratory Diseases.

Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine

A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine

Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific

A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults

A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.

Ventilator Hyperinflation and Hemodynamics

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057

Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.

Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.

A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD

Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers

Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects

Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine